Canonical ID: NK-fFZJQzy8wtbzJexRMrT4bA
· Entity type: Company
(reference)
Property | Value | Lang | Source dataset | Source ID | First seen | ||
---|---|---|---|---|---|---|---|
Company:country | us | eng | us_la_med_exclusions | us-medla-4ecdc20f2a642d41d4379ed1775d29d0b98f52be | |||
Company:id | 83956f0476cf62fd1410ef663a5c13d8a91b1034 | eng | us_la_med_exclusions | us-medla-4ecdc20f2a642d41d4379ed1775d29d0b98f52be | |||
Company:name | Alcala Pharmaceutical Inc | eng | us_la_med_exclusions | us-medla-4ecdc20f2a642d41d4379ed1775d29d0b98f52be | |||
Company:npiCode | 1255656153 | eng | us_la_med_exclusions | us-medla-4ecdc20f2a642d41d4379ed1775d29d0b98f52be | |||
Company:sector | Lab | eng | us_la_med_exclusions | us-medla-4ecdc20f2a642d41d4379ed1775d29d0b98f52be | |||
Company:topics | debarment | eng | us_la_med_exclusions | us-medla-4ecdc20f2a642d41d4379ed1775d29d0b98f52be |